14-19921004-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005483.1(OR4K5):c.398T>A(p.Val133Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001005483.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4K5 | NM_001005483.1 | c.398T>A | p.Val133Glu | missense_variant | 1/1 | ENST00000315915.5 | NP_001005483.1 | |
OR4K1 | XM_011537153.3 | c.-122+692T>A | intron_variant | XP_011535455.1 | ||||
LOC124903278 | XR_007064055.1 | n.166-13922A>T | intron_variant |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 36
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 36
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 28, 2024 | The c.398T>A (p.V133E) alteration is located in exon 1 (coding exon 1) of the OR4K5 gene. This alteration results from a T to A substitution at nucleotide position 398, causing the valine (V) at amino acid position 133 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.